Skip to main content

Nocturnal Enuresis

0
Pipeline Programs
3
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Ferring Pharmaceuticals
Ferring PharmaceuticalsArgentina - Buenos Aires
2 programs
DesmopressinPHASE_31 trial
Primary nocturnal enuresisPHASE_41 trial
Active Trials
NCT01078753Completed89Est. Sep 2010
NCT00245479Completed802Est. Nov 2006
Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
1 program
Nightly Timed AwakeningN/A1 trial
Active Trials
NCT06586476Not Yet Recruiting40Est. Dec 2026
Becton Dickinson
Becton DickinsonFRANKLIN LAKES, NJ
1 program
PureWick™ SystemN/A1 trial
Active Trials
NCT05710718Completed17Est. Aug 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Ferring PharmaceuticalsPrimary nocturnal enuresis
Ferring PharmaceuticalsDesmopressin
Angeles TherapeuticsNightly Timed Awakening
Becton DickinsonPureWick™ System

Clinical Trials (4)

Total enrollment: 948 patients across 4 trials

NCT00245479Ferring PharmaceuticalsPrimary nocturnal enuresis

A Study of Oral Desmopressin in Previously Untreated Children Aged 5 to 15 Years With Primary Nocturnal Enuresis

Start: Apr 2002Est. completion: Nov 2006802 patients
Phase 4Completed
NCT01078753Ferring PharmaceuticalsDesmopressin

Study With Two Different Doses of Desmopressin Orally Lyophilisate Tablet With Nocturnal Enuresis

Start: Jan 2010Est. completion: Sep 201089 patients
Phase 3Completed
NCT06586476Angeles TherapeuticsNightly Timed Awakening

The Role of Timed Awakening in Treatment of Enuresis

Start: Oct 2024Est. completion: Dec 202640 patients
N/ANot Yet Recruiting
NCT05710718Becton DickinsonPureWick™ System

PureWick™ France and U.S. At-Home Pilot Study

Start: Oct 2023Est. completion: Aug 202417 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.